Barclays Hikes Eli Lilly Price Target to $1,400: Tirzepatide Momentum Steals the Show
This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.